Exane Derivatives’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,196
| Closed | -$153K | – | 837 |
|
|
2022
Q1 | $153K | Sell |
1,196
-304
| -20% | -$38.9K | 0.04% | 395 |
|
|
2021
Q4 | $201K | Sell |
1,500
-444
| -23% | -$59.6K | 0.05% | 327 |
|
|
2021
Q3 | $266K | Sell |
1,944
-1,736
| -47% | -$237K | 0.06% | 310 |
|
|
2021
Q2 | $411K | Buy |
3,680
+720
| +24% | +$80.3K | 0.09% | 223 |
|
|
2021
Q1 | $266K | Sell |
2,960
-1,276
| -30% | -$115K | 0.08% | 240 |
|
|
2020
Q4 | $392K | Buy |
+4,236
| New | +$392K | 0.12% | 202 |
|